Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 1893-1903

  Yano, S ^a   Shinohara, H ^a   Herbst, R S ^a   Kuniyasu, H ^a   Bucana, C D ^a   Ellis, L M ^a   Fidler, I J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE RECEPTOR; VASCULOTROPIN;

ADVANCED CANCER; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER CELL; CANCER INVASION; CANCER STAGING; HUMAN; HUMAN CELL; IMPLANTATION; LUNG CANCER; LUNG PARENCHYMA; MALIGNANT NEOPLASTIC DISEASE; MESSENGER RNA SYNTHESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SQUAMOUS CELL CARCINOMA;

EID: 0033634847     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64828-6     Document Type: Article

References (44)

1. Cancer statistics, CA
2. Common lung cancers
3. Management of the malignant pleural effusion
4. Management of malignant pleural effusions
5. Prognostic value of pleural effusion in patients with non-small cell lung cancer
6. Pleural effusion as a significant prognostic factor in non-small cell lung cancer
7. Pleural sclerosis for the treatment of pneumothorax and pleural effusion
8. Diagnosis and treatment of malignant pleural effusion
9. The role of vascular endothelial growth factor in the regulation of blood vessel growth
10. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
11. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
12. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
13. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
14. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells
15. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
16. Regulation of distinct steps of angiogenesis by different angiogenic molecules
17. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
18. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation
19. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
20. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors
21. Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice
22. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines
23. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma
24. Density-dependent induction of 92-kDa type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells
25. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
26. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats: Involvement of the glucocorticoid receptor and vascular permeability factor
27. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
28. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
29. Downregulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation
30. Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family
31. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density
32. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
33. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin
34. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
35. Vascular endothelial growth factor induces endothelial fenestrations in vitro
36. Vascular-derived growth factors: Potential role in the development of the tumor vasculature
37. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression
38. Invasion of connective tissue by human carcinoma cell lines: Requirement for urokinase, urokinase receptor, and interstitial collagenase
39. Urokinase-type plasminogen activator in carcinomatous pleural fluid
40. Malignant pleural effusion: Would the real cause please stand up?
41. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
42. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
43. Pleural effusion in lung cancer
44. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer